Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Shares Issued: 2020-2025

Historic Shares Issued for Roivant Sciences (ROIV) over the last 3 years, with Sep 2025 value amounting to $68.3 million.

  • Roivant Sciences' Shares Issued rose 931.63% to $68.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.0 million, marking a year-over-year decrease of 63.36%. This contributed to the annual value of $49.6 million for FY2025, which is 75.18% down from last year.
  • Latest data reveals that Roivant Sciences reported Shares Issued of $68.3 million as of Q3 2025, which was up 127.21% from $30.1 million recorded in Q2 2025.
  • Roivant Sciences' 5-year Shares Issued high stood at $199.8 million for Q4 2023, and its period low was $2.3 million during Q2 2024.
  • Its 3-year average for Shares Issued is $68.0 million, with a median of $33.5 million in 2024.
  • Its Shares Issued has fluctuated over the past 5 years, first plummeted by 96.30% in 2024, then spiked by 1,223.51% in 2025.
  • Over the past 4 years, Roivant Sciences' Shares Issued (Quarterly) stood at $94.7 million in 2022, then surged by 110.93% to $199.8 million in 2023, then crashed by 81.48% to $37.0 million in 2024, then skyrocketed by 931.63% to $68.3 million in 2025.
  • Its Shares Issued was $68.3 million in Q3 2025, compared to $30.1 million in Q2 2025 and $37.0 million in Q4 2024.